Pacer Advisors
LJPC

Pacer Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Pacer Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,474
Closed -$90K – 1219
2018
Q3 		$90K Buy
+4,474
New +$117K ﹤0.01% 1102
2018
Q1 		– Sell
-625
Closed -$20K – 1206
2017
Q4 		$20K Buy
+625
New +$20.4K ﹤0.01% 1097

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors's LJPC Position: Q4 2018 in Review

Pacer Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2018, closing a stake of 4,474 shares — an estimated $90K sold.

Pacer Advisors first reported a position in LJPC in Q4 2017 and held it in 2 quarters. The position peaked at $90K in Q3 2018. 83 funds tracked by Wall St. Rank hold LJPC as of Q4 2018.

  • Pacer Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q4 2018 after selling out during the quarter.
  • Pacer Advisors sold 4,474 La Jolla Pharmaceutical Company shares in Q4 2018, an estimated $90K.
  • Pacer Advisors first reported a position in La Jolla Pharmaceutical Company in Q4 2017 and held it in 2 quarters.
  • Pacer Advisors's La Jolla Pharmaceutical Company position peaked at $90K in Q3 2018.
  • 83 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2018.

Based on Pacer Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.